N-[2-(2-AMINO-6,6-DISUBSTITUTED-4, 4A, 5, 6-TETRAHYDROPYRANO [3,4-D][1,3] THIAZIN-8A (8H)-YL) -1, 3-THIAZOL-4-YL] AMIDES

and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Saved in:
Bibliographic Details
Main Authors BRODNEY, Michael Aaron, ZHANG, Lei, VERHOEST, Patrick Robert, MIKOCHIK, Peter Justin, BUTLER, Christopher Ryan, MURRAY, John Charles, O'NEILL, Brian Thomas, HOU, Xinjun
Format Patent
LanguageEnglish
Published 19.12.2018
Online AccessGet full text

Cover

More Information
Summary:and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Bibliography:Application Number: ZA20180001089